Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): A report from the Children's Cancer Group

This publication has 24 references indexed in Scilit:

• Assessment of environmental and genetic factors in the etiology of childhood cancers: the Childrens Cancer Group epidemiology program.
  Environmental Health Perspectives, 1995
• Infant Leukemia, Topoisomerase II Inhibitors, and the MLL Gene
  JNCI Journal of the National Cancer Institute, 1994
• Epipodophyllotoxins and secondary leukaemia
  The Lancet, 1993
• In utero rearrangements in the trithorax-related oncogene in infant leukaemias
  Nature, 1993
• THERAPY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTIONS. PART II: METHODS OF TREATMENT
  International Journal of Dermatology, 1992
• Chromosomal changes in Chinese hamster AA8 cells caused by podophyllin, a common treatment for genital warts
  Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
• Does bulk damage to DNA explain the cytostatic and cytotoxic effects of topoisomerase II inhibitors?
  Biochemical Pharmacology, 1991
• Rapid evaluation of topoisomerase inhibitors: Caffeine inhibition of topoisomerases in vivo
  Teratogenesis, Carcinogenesis, and Mutagenesis, 1990
• Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid Leukemia
  New England Journal of Medicine, 1989
• TOPOISOMERASES IN HUMAN DISEASE
  The Lancet, 1988